Dogwood Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -6.3% | -75.8% | +5,464.4% | -25.3% | -78.6% | +104.3% | +519.3% | |
| – | +24.4% | +612.1% | -50.6% | -12.4% | -12.4% | +133.8% | -29.8% | |
| – | +11.1% | +359.3% | +56.3% | -21.3% | -55.8% | +124.5% | +128.7% | |
| – | – | – | – | – | – | – | – | |
| – | +94.0% | +30.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.